Besides the impacts on organs traditionally associated with the development of hyperglycemia, isoflavones have been shown to reduce the progression of chronic kidney disease and affect glucose reabsorption, potentiate incretins action, modify the composition of the intestinal microflora, and increase hypothalamic appetite control. The gene discussed is GCG; the disease is Hyperglycemia.